Next Article in Journal
MiRNAs Action and Impact on Mitochondria Function, Metabolic Reprogramming and Chemoresistance of Cancer Cells: A Systematic Review
Next Article in Special Issue
Deep-Learning-Based Automated Identification and Visualization of Oral Cancer in Optical Coherence Tomography Images
Previous Article in Journal
Insulin-like Growth Factor-1 Prevents Hypoxia/Reoxygenation-Induced White Matter Injury in Sickle Cell Mice
Previous Article in Special Issue
Psychosocial Adjustment Changes and Related Factors in Postoperative Oral Cancer Patients: A Longitudinal Study
 
 
Review
Peer-Review Record

Deciphering the Functions of Telomerase Reverse Transcriptase in Head and Neck Cancer

Biomedicines 2023, 11(3), 691; https://doi.org/10.3390/biomedicines11030691
by Tsung-Jang Yeh 1,2,3, Chi-Wen Luo 4,5, Jeng-Shiun Du 1,2,3, Chien-Tzu Huang 1,2, Min-Hung Wang 1,2, Tzer-Ming Chuang 1,3, Yuh-Ching Gau 1,2,3, Shih-Feng Cho 1,2,3, Yi-Chang Liu 1,2, Hui-Hua Hsiao 1,2, Li-Tzong Chen 3,6,7, Mei-Ren Pan 2,8,9, Hui-Ching Wang 1,2,3,* and Sin-Hua Moi 2,*
Biomedicines 2023, 11(3), 691; https://doi.org/10.3390/biomedicines11030691
Submission received: 9 February 2023 / Revised: 19 February 2023 / Accepted: 22 February 2023 / Published: 24 February 2023
(This article belongs to the Special Issue Oral Cancer: From Pathophysiology to Novel Therapeutic Approaches)

Round 1

Reviewer 1 Report

This review lacks a proper introduction/description of the evidence for the re-expression of TERT by these mutations in the promoter in the TERT gene in various cancers.  

Do these mutations in the TERT promoter alsways result in the re-expression of TERT?  What degrees of the re-expression were observed associated with these mutations? Are these levels of the re-expression biologically relevant?

It is also better to include the information on the expression status of TERT in the studies listed in Table2 if it was investigated.  

Please cite these publications properly.

Bell RJA, Rube HT, Kreig A, Mancini A, Fouse SD, Nagarajan RP, et al. Cancer. The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer. Science. 2015;348:1036–9.

Stern JL, Theodorescu D, Vogelstein B, Papadopoulos N, Cech TR. Mutation of the TERT promoter, switch to active chromatin, and monoallelic TERT expression in multiple cancers. Genes Dev. 2015;29:2219–24.

Author Response

Please see the attachment.

Author Response File: Author Response.pdf

Reviewer 2 Report

In this manuscript authors study how the telomerase reverse transcriptase  ummarize their understanding and evidence of TERT promoter mutations in head and neck cancer patients, a scientifically sound issue nowadays.

This article is clear, comprehensive and well-structure. Figures and tables are easy to understand and interpret, and show the data properly.

Statements and conclusions are consistent with the evidence and arguments presented and they have relevance to the field.

References are current (only 12/142 from more than ten years ago), relevant and there is not an excessive number of self-citations.

In general, I consider this article has interest to the scientific community.

Author Response

Please see the attachment.

Author Response File: Author Response.pdf

Round 2

Reviewer 1 Report

The authors responded to my comments satisfactory.  

Back to TopTop